Connor, Clark & Lunn Investment Management »

Neuropace shares owned by Connor, Clark & Lunn Investment Management

Quarter-by-quarter ownership of Neuropace (NPCE) shares owned by Connor, Clark & Lunn Investment Management from 13F filings

Historical chart of Connor, Clark & Lunn Investment Management investment in Neuropace

Tip: Access up to 7 years of quarterly data

All positions including Neuropace held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neuropace by Connor, Clark & Lunn Investment Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $900k 58k 15.44

More positions owned by Connor, Clark & Lunn Investment Management

Rbc Cad (RY)
Agnico (AEM)
Shopify Cl A Sub Vtg Shs (SHOP)
Toronto Dominion Bk Ont Com New (TD)
Cibc Cad (CM)
NVIDIA Corporation (NVDA)
Bk Nova Cad (BNS)
Apple (AAPL)
Invesco Exch Traded Fd Tr Ii Purbta Msci Us (PBUS)
Microsoft Corporation (MSFT)
Tc Energy Corp (TRP)
Celestica (CLS)
Enbridge (ENB)
Amazon (AMZN)
Barrick Mng Corp Com Shs (B)

View all positions for Connor, Clark & Lunn Investment Management

Top funds holding Neuropace

Polar Capital Holdings
Soleus Capital Management
OrbiMed Advisors
BlackRock
Vanguard Group
First Light Asset Management
Armistice Capital
Kent Lake PR
Driehaus Capital Management
Deutsche Bank Aktiengesellschaft
FMR
Geode Capital Management
State Street Corporation
Silvercrest Asset Management Group
Nantahala Capital Management

View all funds holding Neuropace